Emerging Prospects in PLK1 Inhibitors: A DelveInsight Perspective

adicionou um novo artigo Health

2025-09-21 10:34:12

Polo-like kinase 1 (PLK1) has become a key target in oncology due to its essential role in cell cycle control and mitosis. With increasing scientific validation and a deeper grasp of tumor biology, the PLK1 inhibitor Market is gaining attention from both established pharmaceutical companies and agile biotech firms striving to convert mechanistic promise into tangible clinical benefits. This...

0 Comentários 0 Compartilhamentos 574 Visualizações 0 Anterior